Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Stephen A. Ballard
Observed names:
S A Ballard,
S. A. BALLARD,
S.A. BALLARD,
S.A. Ballard,
STEPHEN A. BALLARD,
Stephen A Ballard,
Stephen Ballard
show all 7
Institution:
Pfizer (United Kingdom)
Observed institutions:
Pfizer (United States),
Pfizer (United Kingdom),
Vanderbilt University,
University of Kent,
Southmead Hospital,
University College London
show all 6
OpenAlex ID:
A5046909172
Effects of Sildenafil on the Relaxation of Human Corpus Cavernosum Tissue in Vitro and on the Activities of Cyclic Nucleotide Phosphodiesterase Isozymes
1998
·
STEPHEN A. BALLARD
, CLIVE J. GINGELL
, et al.
·
The Journal of Urology
·
583
Effects of sildenafil, a type‐5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro
1997
·
J.Y. JEREMY
, S.A. BALLARD
, et al.
·
British Journal of Urology
·
237
Inhibition of Cyclic GMP-Binding Cyclic GMP-Specific Phosphodiesterase (Type 5) by Sildenafil and Related Compounds
1999
·
Illarion V. Turko
, Stephen A. Ballard
, et al.
·
Molecular Pharmacology
·
193
Pharmacological Options in the Treatment of Benign Prostatic Hyperplasia
1997
·
Barry Kenny
, Stephen Ballard
, et al.
·
Journal of Medicinal Chemistry
·
167
Effect of the Selective Phosphodiesterase Type 5 Inhibitor Sildenafil on Erectile Function in the Anesthetized Dog
1998
·
ANTHONY J. CARTER
, STEPHEN A. BALLARD
, et al.
·
The Journal of Urology
·
91
A comparative study of 1-substituted imidazole and 1,2,4-triazole antifungal compounds as inhibitors of testosterone hydroxylations catalysed by mouse hepatic musomal cytochromes P-450
1988
·
Stephen A. Ballard
, Alberto Lodola
, et al.
·
Biochemical Pharmacology
·
48
Interaction of microsomal cytochrome P-450 isolated fromAspergillus fumigatuswith fluconazole and itraconazole
1990
·
S.A. Ballard
, S.L. Kelly
, et al.
·
Medical Mycology
·
39
The Insulin-Like Growth Factor Type I Receptor Stimulates Growth and Suppresses Apoptosis in Prostatic Stromal Cells
1998
·
Ewan S. Grant
, Margaret B. Ross
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
36
5 alpha-reductase expression by prostate cancer cell lines and benign prostatic hyperplasia in vitro
1996
·
C M Smith
, S A Ballard
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
36
A novel method for studying ergosterol biosynthesis by a cell-free preparation ofAspergillus fumigatusand its inhibition by azole antifungal agents
1990
·
S.A. Ballard
, S.W. Ellis
, et al.
·
Medical Mycology
·
34
The discovery of UK-369003, a novel PDE5 inhibitor with the potential for oral bioavailability and dose-proportional pharmacokinetics
2011
·
David J. Rawson
, Stephen Ballard
, et al.
·
Bioorganic & Medicinal Chemistry
·
29
Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro
1994
·
C.M. Smith
, S.A. Ballard
, et al.
·
The Journal of Steroid Biochemistry and Molecular Biology
·
25
The effect of intravenously administered phosphocreatine on ATP and phosphocreatine concentrations in the cardiac muscle of the rat.
1983
·
W H Down
, L F Chasseaud
, et al.
·
PubMed
·
19
Design and synthesis of long acting inhaled corticosteroids for the treatment of asthma
2011
·
David S. Millan
, Stephen A. Ballard
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
16
The development of non-steroidal dual inhibitors of both human 5α-reductase isozymes
1996
·
J. Blagg
, S.A. Ballard
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
10
Haemodynamic effects of the selective phosphodiesterase 5 inhibitor, UK‐357,903, in conscious SHR
2004
·
Sheila M Gardiner
, Julie E March
, et al.
·
British Journal of Pharmacology
·
6
PDF
Hemodynamic Effects of Phosphodiesterase 5 and Angiotensin-Converting Enzyme Inhibition Alone or in Combination in Conscious SHR
2004
·
S.M. Gardiner
, J.E. March
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
5
Regional Hemodynamic Effects of Neutral Endopeptidase Inhibition and Angiotensin (AT1) Receptor Antagonism Alone or in Combination in Conscious Spontaneously Hypertensive Rats
2006
·
S.M. Gardiner
, J.E. March
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
4
Absorption and elimination of a branched-chain alkylpolyethoxylate surfactant in rats
1983
·
G. Calvin
, L.F. Chasseaud
, et al.
·
Toxicology Letters
·
4
Selective interaction of two N-substituted imidazole antifungal compounds with cytochromes P-450 catalysing ethoxyresorufin O-de-ethylation
1987
·
STEPHEN A. BALLARD
, MICHAEL H. TARBIT
, et al.
·
Biochemical Society Transactions
·
3
UK-500,001, a potent selective inhibitor of phosphodiesterase type 4 (PDE4) designed for inhaled delivery, inhibits TNF-a, MIP-1b and LTB4 released from native blood cells.
2007
·
Michael A. Trevethick
, K.H. Banner
, et al.
·
Kent Academic Repository (University of Kent)
·
1
The effect of caffeine on the absorption of 3H-dihydroergocryptine (DHEC) in the rat.
1980
·
W H Down
, L F Chasseaud
, et al.
·
PubMed
·
1
PF-4357415: A Novel Inhaled Corticosteroid That Demonstrates Superior Potency, Duration And Therapeutic Index To Fluticasone Propionate In The Rat LPS Model
2011
·
David Lamb
, Nicole Parker
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Temporal Characterisation And Modelling Of Fluticasone Propionate-mediated 24 Hour AUC Corticosterone Suppression In Rats
2010
·
David Lamb
, David Fairman
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Ex Vivo LPS-Stimulated TNF± Release As A Measure Of Systemic Corticosteroid Effect In Dogs
2010
·
Christopher A. Hewson
, Derek P. Winslow
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Show more works
View as search
Works count:
26
Citation count:
1,587
H-index:
14
I10-index:
15
Year
Topic
Type
